(7161.24052017.110000322) 7161.24052017.110000322 (Q2061855)
Jump to navigation
Jump to search
Project Q2061855 in Italy
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | (7161.24052017.110000322) 7161.24052017.110000322 |
Project Q2061855 in Italy |
Statements
17,865.91 Euro
0 references
35,731.82 Euro
0 references
50.0 percent
0 references
13 April 2016
0 references
21 October 2019
0 references
4 December 2018
0 references
REGULATORY PHARMA NET S.R.L.
0 references
Q292336 (Deleted Item)
0 references
43°46'11.53"N, 11°15'20.09"E
0 references
REGULATORY PHARMA NET (RPN), FONDATA NEL 1999, ? UNA SOCIET? QUALIFICATA IN CONSULENZA E SERVIZI, SPECIALIZZATA IN REGOLAMENTAZIONE IN AMBITO FARMACEUTICO E MEDICALE. L'APPROCCIO DI RPN SI BASA SU UN LAVORO DI SQUADRA FOCALIZZATO SUL CLIENTE. A LIVELLO INTERNAZIONALE (DATI FARMINDUSTRIA) STIAMO ASSISTENDO AD UN VERO E PROPRIO RECORD STORICO DI FARMACI IN SVILUPPO. L?ITALIA SI POSIZIONA AI PRIMI POSTI AL MONDO PER QUALIT? DELLE PUBBLICAZIONI SCIENTIFICHE IN MEDICINA, FARMACOLOGIA, DRUG DISCOVERY E IN AREE NELLE QUALI SI CONCENTRA LA RICERCA FARMACEUTICA INTERNAZIONALE, QUALI ONCOLOGIA, CARDIOLOGIA E NEUROLOGIA.CON 1,5 MILIARDI INVESTITI IN REAMP;S NEL 2016 (7% DEL TOTALE IN ITALIA) L?INDUSTRIA FARMACEUTICA ? TERZA TRA I SETTORI MANIFATTURIERI, E PRIMA SIA PER QUOTA DI IMPRESE INNOVATIVE SIA PER RAPPORTO TRA SPESE PER INNOVAZIONE E ADDETTI. IL 2016 CONFERMA LA POSIZIONE DI ECCELLENZA DELL?ITALIA PER LA PRODUZIONE FARMACEUTICA NELL?UE: SECONDA IN EUROPA, AL TALLONE DELLA GERMANIA, E CON L (Italian)
0 references
REGULATORY PHARMA NET (RPN), FOUNDED IN 1999? A SOCIETY? QUALIFIED IN ADVICE AND SERVICES, SPECIALISED IN PHARMACEUTICAL AND MEDICAL REGULATION. THE RPN APPROACH IS BASED ON A TEAM WORKING FOCUSED ON THE CLIENT. AT THE INTERNATIONAL LEVEL (DATA FARMINDUSTRIA) WE ARE WITNESSING A TRUE HISTORICAL RECORD OF DEVELOPING MEDICINES. DOES ITALY RANK THE FIRST PLACES IN THE WORLD FOR QUALIT? SCIENTIFIC LITERATURE IN MEDICINE, PHARMACOLOGY, DRUG DISCOVERY AND IN AREAS WHERE INTERNATIONAL PHARMACEUTICAL RESEARCH IS CONCENTRATED, SUCH AS ONCOLOGY, CARDIOLOGY AND NEUROLOGIA.CON OVER 1,5 BILLION RWAR; S IN 2016 (7 % OF THE TOTAL IN ITALY) L? PHARMACEUTICAL INDUSTRY? THIRD, BETWEEN MANUFACTURING SECTORS, AND BEFORE BOTH THE SHARE OF INNOVATIVE FIRMS AND THE RATIO BETWEEN INNOVATION AND EMPLOYEES. 2016 CONFIRMS ITALY’S EXCELLENT POSITION FOR PHARMACEUTICAL PRODUCTION IN THE EU: SECOND IN EUROPE, AT THE GERMAN HEEL, AND WITH (English)
0 references
Identifiers
D54E17002840009
0 references